Testing effectiveness (Phase 2)Study completedNCT02980692What this trial is testingEfficacy and Safety Study of SUNPG1623Who this might be right forActive Psoriatic Arthritis Sun Pharmaceutical Industries Limited 391
Large-scale testing (Phase 3)Active Not RecruitingNCT04908202What this trial is testingDetermine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease-modifying Anti-rheumatic DrugsWho this might be right forPsoriatic Arthritis Bristol-Myers Squibb 670
Large-scale testing (Phase 3)Study completedNCT02662985What this trial is testingStudy of Power Doppler Ultrasound (PDUS) to Measure Response of Secukinumab Treatment in Patients With Active Psoriatic Arthritis (PsA)Who this might be right forPsoriatic Arthritis Novartis Pharmaceuticals 166
Not applicableNot Yet RecruitingNCT07188688What this trial is testingSWE to Detect Enthesitis in PsA: Relationship With SIRT2 Expression and Disease ActivityWho this might be right forShear Wave Elastography Assiut University 57
Not applicableUnknownNCT02572700What this trial is testingPain Mechanisms and Ultrasonographic Disease Activity in Psoriatic ArthritisWho this might be right forPsoriatic ArthritisPsoriasisHealthy Controls Frederiksberg University Hospital 400
Large-scale testing (Phase 3)Study completedNCT03895203What this trial is testingTest the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic ArthritisWho this might be right forPsoriatic Arthritis UCB Biopharma SRL 852
Large-scale testing (Phase 3)Study completedNCT04711902What this trial is testingStudy of Efficacy and Safety of Secukinumab in Chinese Subjects With Active PsA Compared to Placebo.Who this might be right forPsoriatic Arthritis Novartis Pharmaceuticals 41
Testing effectiveness (Phase 2)Study completedNCT00646386What this trial is testingStudy of the Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Moderately to Severely Active Psoriatic ArthritisWho this might be right forArthritisPsoriatic Abbott 315
Post-approval studies (Phase 4)Not Yet RecruitingNCT07111494What this trial is testingImpact of Glucagon-like Peptide-1 (GLP-1) Analogs on Disease Outcomes in Psoriatic Arthritis: A Pragmatic Randomized Controlled TrialWho this might be right forPsoriatic Arthritis (PsA) Medical College of Wisconsin 22
Large-scale testing (Phase 3)Study completedNCT02721966What this trial is testingStudy of the Efficacy and Safety of Secukinumab in Participants With Active Psoriatic Arthritis With Axial Skeleton InvolvementWho this might be right forAxial Psoratic Arthritis Novartis Pharmaceuticals 503
Testing effectiveness (Phase 2)Study completedNCT03926195What this trial is testingStudy to Evaluate the Effect of Filgotinib on Semen Parameters in Adult Males With Active Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, or Non-radiographic Axial SpondyloarthritisWho this might be right forRheumatoid ArthritisPsoriatic ArthritisAnkylosing Spondylitis+1 more Galapagos NV 109
Large-scale testing (Phase 3)Study completedNCT01087788What this trial is testingCertolizumab Pegol in Subjects With Adult Onset Active and Progressive Psoriatic ArthritisWho this might be right forArthritis, Psoriatic UCB BIOSCIENCES GmbH 409
Not applicableLooking for participantsNCT04876781What this trial is testingKorean Post-marketing Surveillance for Xeljanz XRWho this might be right forActive Moderate to Severe Rheumatoid ArthritisActive Ankylosing SpondylitisActive Psoriatic Arthritis Pfizer 200
Large-scale testing (Phase 3)Ended earlyNCT05623345What this trial is testingPsoriatic Arthritis Study of IzokibepWho this might be right forPsoriatic Arthritis ACELYRIN Inc. 351
Large-scale testing (Phase 3)Study completedNCT03796858What this trial is testingGuselkumab in Participants With Active Psoriatic Arthritis and an Inadequate Response to Anti-Tumor Necrosis Factor Alpha (Anti-TNF Alpha) TherapyWho this might be right forArthritis, Psoriatic Janssen Pharmaceutica N.V., Belgium 285
Not applicableStudy completedNCT02598739What this trial is testingEvaluation of the Effectiveness of Resistance Training in Patients With Psoriatic ArthritisWho this might be right forPsoriatic Arthritis Federal University of São Paulo 41
Large-scale testing (Phase 3)Study completedNCT00367237What this trial is testingRemicade Study in Psoriatic Arthritis Patients Of Methotrexate-Naïve Disease (RESPOND) (Study P04422)Who this might be right forArthritis, Psoriatic Merck Sharp & Dohme LLC 115
Large-scale testing (Phase 3)Not Yet RecruitingNCT07295509What this trial is testingPicankibart in Patients With Active Psoriatic ArthritisWho this might be right forPsoriatic Arthritis Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD. 222
Testing effectiveness (Phase 2)Study completedNCT05640245What this trial is testingEvaluation of Sonelokimab for the Treatment of Patients With Active Psoriatic ArthritisWho this might be right forArthritis, Psoriatic MoonLake Immunotherapeutics AG 207
Testing effectiveness (Phase 2)Study completedNCT02349451What this trial is testingInvestigate the Safety, Tolerability and Efficacy of ABT-122 in Subjects With Active Psoriatic Arthritis (PsA) Who Have an Inadequate Response to Methotrexate (MTX)Who this might be right forPsoriatic Arthritis AbbVie 240